Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Biochemical markers of liver fibrosis in HCV patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Detection of HCV in peripheral blood mononuclear cells of serum HCV negative patients under Interferon treatment

3 Biochemical markers in blood can predict cirrhotic evolution of chronic hepatitis

In vitro study of neutrophilapoptosis in chronic hepatitis C patients

Study of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Determination of serum levels ofmalondialdehyde and ceruloplasmin in HCV patients